Skip to main content

Summit Trail Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1698478 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5,553,274
-$555,452 QoQ
Shares Held
43,955
+0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#557
of 2,266 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Summit Trail Advisors, LLC holds $121,589,141 across 15 Drug Manufacturers - General names. GILD ranks #6 (4.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
43,955 $5,553,274

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,553,274 43,955
2026-03-31 $6,108,726 43,831
2025-12-31 $4,408,084 35,914
2025-09-30 $4,670,103 42,073
2025-06-30 $4,437,017 40,020
2024-09-30 $1,750,914 20,884
2024-06-30 $1,173,574 17,105
2024-03-31 $909,911 12,422
2023-12-31 $1,001,040 12,357
2023-09-30 $932,928 12,449
2023-06-30 $925,225 12,005
2023-03-31 $739,677 8,915
2022-12-31 $507,802 5,915
2022-09-30 $414,865 6,725
2021-09-30 $238,887 3,420
2021-06-30 $216,013 3,137
2021-03-31 $206,816 3,200
2020-12-31 $206,997 3,553
2020-06-30 $204,506 2,658